• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22366 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2024     Agency for Care Effectiveness (ACE) Pembrolizumab for the adjuvant treatment of renal cell carcinoma
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Pembrolizumab for the treatment of advanced melanoma
2024     Agency for Care Effectiveness (ACE) Pembrolizumab for treating high-risk early-stage triple-negative breast cancer
2021     National Institute for Health and Care Excellence (NICE) Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy. NICE technology appraisal guidance 692
2024     Agency for Care Effectiveness (ACE) Pembrolizumab for treating persistent, recurrent, or metastatic cervical cancer
2019     National Institute for Health and Care Excellence (NICE) Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal). NICE technology appraisal guidance 570
2022     National Institute for Health and Care Excellence (NICE) Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies. NICE technology appraisal guidance 772
2018     National Institute for Health and Care Excellence (NICE) Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma. NICE technology appraisal guidance 540
2021     National Institute for Health and Care Excellence (NICE) Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency. NICE technology appraisal guidance 709
2020     National Institute for Health and Care Excellence (NICE) Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma. NICE technology appraisal guidance 661
2018     National Institute for Health and Care Excellence (NICE) Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer. NICE technology appraisal guidance 531
2021     National Institute for Health and Care Excellence (NICE) Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal). NICE technology appraisal guidance 674
2022     National Institute for Health and Care Excellence (NICE) Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer. NICE technology appraisal guidance 801
2023     National Institute for Health and Care Excellence (NICE) Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer. NICE technology appraisal guidance 885
2023     National Institute for Health and Care Excellence (NICE) Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer. NICE technology appraisal guidance 939
2020     National Institute for Health and Care Excellence (NICE) Pembrolizumab with axitinib for untreated advanced renal cell carcinoma. NICE technology appraisal guidance 650
2022     National Institute for Health and Care Excellence (NICE) Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer. NICE technology appraisal guidance 770
2023     National Institute for Health and Care Excellence (NICE) Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer. NICE technology appraisal guidance 904
2021     National Institute for Health and Care Excellence (NICE) Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer. NICE technology appraisal guidance 683
2021     National Institute for Health and Care Excellence (NICE) Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancer. NICE technology appraisal guidance 737
2010     NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) for recurrent or newly diagnosed metastatic head and neck cancer
2008     NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) monotherapy as maintenance therapy for non-small cell lung cancer
2008     NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium (Alimta) monotherapy as maintenance therapy for non-small cell lung cancer
2002     NIHR Horizon Scanning Centre (NIHR HSC) Pemetrexed disodium for mesothelioma and NSCLC - horizon scanning review
2007     NIHR Health Technology Assessment programme Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation
2008     National Institute for Health and Care Excellence (NICE) Pemetrexed disodium for the treatment of mesothelioma
2013     NIHR Health Technology Assessment programme Pemetrexed for maintenance treatment following induction therapy with pemetrexed and cisplatin for non-squamous non-small cell lung cancer
2010     NIHR Health Technology Assessment programme Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
2009     National Institute for Health and Care Excellence (NICE) Pemetrexed for the first-line treatment of non-small-cell lung cancer
2010     NIHR Health Technology Assessment programme Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
2010     National Institute for Health and Care Excellence (NICE) Pemetrexed for the maintenance treatment of non-small-cell lung cancer
2008     Quality Improvement Scotland (NHS QIS ) Pemetrexed for the treatment of malignant pleural mesothelioma
2007     National Institute for Health and Care Excellence (NICE) Pemetrexed for the treatment of non-small-cell lung cancer
2007     Quality Improvement Scotland (NHS QIS ) Pemetrexed for the treatment of non-small-cell lung cancer
2006     NIHR Health Technology Assessment programme Pemetrexed for the treatment of relapsed non-small cell lung cancer
2021     National Institute for Health and Care Excellence (NICE) Pemigatinib for treating relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangement. NICE technology appraisal guidance 722
2014     Health Council of the Netherlands Gezondheidsraad (GR) Penicillamine - Evaluation of the effects on reproduction, recommendation for classification
2005     NIHR Horizon Scanning Centre (NIHR HSC) Penile cuff test, CT3000 (non-invasive bladder function test) for men with lower urinary tract symptoms - horizon scanning review
2008     HAYES, Inc. Pentacel (Sanofi Pasteur Ltd.) for active immunization of infants and children
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Pentazocine versus short-acting opioids for chronic or acute pain: a review of the clinical effectiveness
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Pentosan polysulfate sodium (Elmiron®) for the treatment of bladder pain syndrome characterized by either glomerulations or Hunner’s lesions
2019     National Institute for Health and Care Excellence (NICE) Pentosan polysulfate sodium for treating bladder pain syndrome. NICE technology appraisal guidance 610
2010     Adelaide Health Technology Assessment (AHTA) Penumbra system for endovascular thrombus removal for treatment of ischaemic stroke patients
2014     NIHR Horizon Scanning Centre (NIHR HSC) Peramivir for acute uncomplicated influenza in adults
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Perampanel (Fycompa - Eisai Ltd.) indication: epilepsy, partial-onset seizures
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Perampanel (Fycompa®)
2014     NIHR Horizon Scanning Centre (NIHR HSC) Perampanel for adjuvant treatment of primary generalised tonic-clonic seizures
2011     NIHR Horizon Scanning Centre (NIHR HSC) Perampanel for epilepsy - adjunctive
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Perceval S sutureless valve for aortic valve replacement: a review of the clinical effectiveness, safety, and cost-effectiveness
2022     WorkSafeBC Percussion therapy for neuropathic pain
2004     HAYES, Inc. Percutaneous alcohol ablation for palliative treatment of pain
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Percutaneous aortic valve replacement. Systematic review
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Percutaneous aortic valve replacement. Systematic review - 1st update 2009
2023     Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous aspiration thrombectomy for pulmonary embolism
2011     National Institute for Health and Care Excellence (NICE) Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices: guidance
2006     National Institute for Health and Care Excellence (NICE) Percutaneous cementoplasty for palliative treatment of bony malignancies
2010     National Institute for Health and Care Excellence (NICE) Percutaneous closure of patent foramen ovale for recurrent migraine
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Percutaneous closure of patent foramen ovale for stroke prevention
2005     National Institute for Clinical Excellence (NICE) Percutaneous closure of patent foramen ovale for the prevention of cerebral embolic stroke
2010     National Institute for Health and Care Excellence (NICE) Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers
2002     Norwegian Knowledge Centre for the Health Services (NOKC) Percutaneous coronary intervention for myocardial infarction
2022     Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous coronary interventions (PCI) for chronic total occlusion (CTO). Update 2022
2014     HAYES, Inc. Percutaneous cryoablation for the treatment of renal masses
2008     HAYES, Inc. Percutaneous cryoablation for treatment of renal cell cancer
2014     HAYES, Inc. Percutaneous disc decompression for cervical disc herniation
2006     National Institute for Health and Care Excellence (NICE) Percutaneous disc decompression using coblation for lower back pain
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Percutaneous disc volume reduction with focus on chemonucleolysis. Update 2017
2004     Washington State Department of Labor and Industries (WSDLI) Percutaneous discectomy for disc herniation
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Percutaneous electrical nerve stimulation
2017     HAYES, Inc. Percutaneous electrical nerve stimulation for treatment of low back pain
2006     National Institute for Health and Care Excellence (NICE) Percutaneous endoscopic colostomy
1999     West Midlands Health Technology Assessment Collaboration (WMHTAC) Percutaneous endoscopic gastrostomy (PEG) feeding in the enteral nutrition of dysphagic stroke patients
2004     National Institute for Clinical Excellence (NICE) Percutaneous endoscopic laser thoracic discectomy
2017     HAYES, Inc. Percutaneous endoscopic lumbar discectomy for primary lumbar disc herniation
2013     HAYES, Inc. Percutaneous epidural adhesiolysis for chronic back pain
2012     HAYES, Inc. Percutaneous epidural adhesiolysis for chronic back pain
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Percutaneous epidural neurolysis and endoscopic neurolysis for the treatment of chronic low back pain
2011     HAYES, Inc. Percutaneous ethanol ablation for hepatocellular carcinoma
1997     Alberta Heritage Foundation for Medical Research (AHFMR) Percutaneous ethanol injection therapy as a treatment for hepatic cancer
2007     HAYES, Inc. Percutaneous extracorporeal transseptal ventricular support using the TandemHeart PTVA system (CardiacAssist Inc.) for cardiogenic shock and high-risk cardiac interventions
2006     National Institute for Health and Care Excellence (NICE) Percutaneous fetal balloon valvuloplasty for aortic stenosis
2006     National Institute for Health and Care Excellence (NICE) Percutaneous fetal balloon valvuloplasty for pulmonary atresia with intact ventricular septum
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Percutaneous hallux valgus surgical correction
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Percutaneous hallux valgus surgical correction
2008     Belgian Health Care Knowledge Centre (KCE) Percutaneous heart valve implantation in congenital and degenerative valve disease. A rapid Health Technology Assessment
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Percutaneous heart valve replacement
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Percutaneous heart valve replacement for valvular heart disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Percutaneous heart valves for valvular heart disease: an updated review of the clinical and cost-effectiveness and guidelines
2023     Health Technology Wales (HTW) Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure
2013     New Zealand National Health Committee (NHC) Percutaneous interventions for mitral regurgitation - technology Note
2004     National Institute for Clinical Excellence (NICE) Percutaneous intradiscal electrothermal therapy for lower back pain
2010     National Institute for Health and Care Excellence (NICE) Percutaneous intradiscal laser ablation in the lumbar spine
2002     Blue Cross Blue Shield Association (BCBS) Percutaneous intradiscal radiofrequency thermocoagulation for chronic discogenic low back pain
2004     Blue Cross Blue Shield Association (BCBS) Percutaneous intradiscal radiofrequency thermocoagulation for chronic discogenic low back pain
2004     National Institute for Clinical Excellence (NICE) Percutaneous intradiscal radiofrequency thermocoagulation for lower back pain
2012     HAYES, Inc. Percutaneous kyphoplasty
2008     HAYES, Inc. Percutaneous kyphoplasty
2017     HAYES, Inc. Percutaneous kyphoplasty for osteoporotic vertebral compression fractures
2006     ECRI Percutaneous kyphoplasty for the treatment of vertebral fractures
2004     Blue Cross Blue Shield Association (BCBS) Percutaneous kyphoplasty for vertebral fractures caused by osteoporosis and malignancy